Abstract
Psychopathy is a personality disorder characterized by a constellation of interpersonal, affective, lifestyle, and antisocial features. However, its neural underpinnings remain poorly understood because functional neuroimaging studies have produced disparate findings. Here, we tackled this lack of replication by investigating whether peak coordinates of studies on psychopathy could in fact map onto a common functional connectivity network. An updated meta-analysis of 23 functional neuroimaging studies (534 cases vs 594 controls) first revealed no significant regional spatial convergence. However, using functional connectomes of 1,000 healthy participants, we demonstrated that the heterogeneous study findings do indeed converge onto a common brain network with a replicability reaching up to 85.2% across studies. We subsequently showed strong associations between this Psychopathy Network and a lesion network of 17 lesion sites causally linked to antisocial behaviors, as well as its association with neurotransmission systems and genetic markers previously implicated in the pathophysiology of psychopathy. Taken together, our study highlights the importance of examining the neural correlates of psychopathy from a network perspective, which can be validated using a multilevel approach, encompassing neural, genetic and neurochemical data. Ultimately, this approach may pave the way for novel and more personalised treatments.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any specific funding. JRD is holder of a postdoctoral fellowship from the Canadian Institutes of Health Research (MFE-181885). SADB was supported by an Economic and Social Research Council Grant (ES/V003526/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Preprocessed resting-state data from the Brain Genomics Superstruct Project is available on the Harvard Dataverse (https://www.neuroinfo.org/gsp).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Peak coordinates of neuroimaging studies included in the meta-analysis can be obtained from the corresponding author on request. Preprocessed resting-state data from the Brain Genomics Superstruct Project is available on the Harvard Dataverse (https://www.neuroinfo.org/gsp).
